Work

Antihyperlipidemic Activity of Gut-Restricted LXR Inverse Agonists

Year: 2022

Type: article

Source: ACS Chemical Biology

DOI: 10.1021/acschembio.2c00057

Authors: Kristine Griffett, Matthew Hayes, Gonzalo Bedia-Diaz, Kevin Appourchaux, Ryan Sanders, Michael P. Boeckman, Thomas Koelblen, Jinsong Zhang, Ira G. Schulman, Bahaa Elgendy, Thomas P. Burris

Institutions: Auburn University, University of Florida, University of Health Sciences and Pharmacy, Washington University in St. Louis, Saint Louis University, University of Virginia

Language: English

Topic: Cholesterol and Lipid Metabolism

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: American Heart Association, National Institute of Diabetes and Digestive and Kidney Diseases

Awards: G1204592513, LXRs Link Lipid Metabolism and Inflammation, Investigating the LXR-Acat2 Connection for the Treatment of Atherosclerosis

OpenAlex ID: W4223931846

FWCI: 2.322

Cites: 39

Cited by: 14

Related to: 10